# Phase 3 Biotech Fund, LP — Form D

Phase 3 Biotech Fund, LP of HIGHLANDS RANCH, CO, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-03-16. $411K was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2020-03-16
- Form: D
- Accession: 0001806165-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $411K
- Investors: 4
- Date of first sale: 2020-03-02
- Security types: fund interests
- SEC file number: 021-362948

## Issuer

- Name: Phase 3 Biotech Fund, LP
- CIK: 0001806165
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 51 FALCON HILLS DRIVE, HIGHLANDS RANCH, CO, 80126
- Phone: 650-838-4434

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Gordon Andringa | Executive Officer | Highlands Ranch, CO |
| a Delaware limited liability company Phase 3 Biotech Fund GP, LLC | Executive Officer | Highlands Ranch, CO |

## More

- [CIK 1806165 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1806165&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001806165-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.